EUVIMEDEUVIMED entdecken
Open Access

Veraguamide E, a Marine Cyanobacterial Depsipeptide Targeting σ 2 R/TMEM97: Chemical and Neurobiological Characterization

Jesus E Sotelo-Morales, Sahar Mofidi Tabatabaei, Christian K Fofie, Kelvin K Fosu iD, Joseph B Dodd-O, Rebekah D Simcik iD, See H Tack, Miguel J Soto-Reyes, Muhammad Saad Yousuf iD, Eduardo J E Caro-Diaz iD, Vivek A Kumar iD, Wade D Van Horn iD und 2 weitere

Journal of Natural Products · 2025

DOI: 10.1021/acs.jnatprod.5c01092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Natural Products, 2025. Verfasst von Jesus E Sotelo-Morales und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Department of Neuroscience, and Center for Advanced Pain Studies, University of Texas at Dallas, Richardson, Texas…. Hauptthemen laut MEDLINE: Cyanobacteria, Depsipeptides, Receptors, sigma, Membrane Proteins. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCCIH NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyanobacteriaDepsipeptidesReceptors, sigmaMembrane ProteinsAnimalsHumansMiceMolecular StructureCalciumInduced Pluripotent Stem Cells

Substanzen

DepsipeptidesReceptors, sigmasigma-2 receptorCalciumMembrane Proteins

Autor:innen und Institutionen

  • Department of Biological Sciences, Department of Neuroscience, and Center for Advanced Pain Studies, University of Texas at Dallas, Richardson, Texas 75080, United States.
  • Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40536, United States.
  • Biodesign Center for Personalized Diagnostics and School of Molecular Sciences, Arizona State University, Tempe, Arizona 85287, United States.
  • Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.
  • Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico - Medical Sciences Campus, San Juan, Puerto Rico 00936, United States.
  • Department of Biomedical Engineering, University of Houston, Houston, Texas 77004, United States.

ORCID-Profile: Kelvin K Fosu, Rebekah D Simcik, Muhammad Saad Yousuf, Eduardo J E Caro-Diaz, Vivek A Kumar, Wade D Van Horn, Benedict Kolber, Kevin J Tidgewell

Förderung

  • NIGMS NIH HHS
  • NCCIH NIH HHS
  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • Fogarty International Center
  • National Center for Complementary and Integrative Health
  • Smithsonian Tropical Research Institute
  • National Institutes of Health

Zitieren

APA

Sotelo-Morales, J. E., Mofidi Tabatabaei, S., Fofie, C. K., Fosu, K. K., Dodd-O, J. B., Simcik, R. D., Tack, S. H., Soto-Reyes, M. J., Yousuf, M. S., Caro-Diaz, E. J. E., Kumar, V. A., Van Horn, W. D., Kolber, B., & Tidgewell, K. J. (2025). Veraguamide E, a Marine Cyanobacterial Depsipeptide Targeting σ 2 R/TMEM97: Chemical and Neurobiological Characterization. Journal of Natural Products. https://doi.org/10.1021/acs.jnatprod.5c01092

Vancouver

Sotelo-Morales JE, Mofidi Tabatabaei S, Fofie CK, Fosu KK, Dodd-O JB, Simcik RD, et al. Veraguamide E, a Marine Cyanobacterial Depsipeptide Targeting σ 2 R/TMEM97: Chemical and Neurobiological Characterization. Journal of Natural Products. 2025. doi:10.1021/acs.jnatprod.5c01092

BibTeX
@article{SoteloMorales2025,
  author = {Sotelo-Morales, Jesus E and Mofidi Tabatabaei, Sahar and Fofie, Christian K and Fosu, Kelvin K and Dodd-O, Joseph B and Simcik, Rebekah D and Tack, See H and Soto-Reyes, Miguel J and Yousuf, Muhammad Saad and Caro-Diaz, Eduardo J E and Kumar, Vivek A and Van Horn, Wade D and Kolber, Benedict and Tidgewell, Kevin J},
  title = {Veraguamide E, a Marine Cyanobacterial Depsipeptide Targeting σ 2 R/TMEM97: Chemical and Neurobiological Characterization},
  journal = {Journal of Natural Products},
  year = {2025},
  doi = {10.1021/acs.jnatprod.5c01092}
}
Kostenlos starten →